Inventor
WU QIAOYIN
US20 patents
⚠️ This page may combine multiple inventors who share the name “WU QIAOYIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GILEAD SCIENCES INC
15 patentsUS10836746B2Nov 17, 2020
Therapeutic compounds
GILEAD SCIENCES INC20 citations94
US11084832B2Aug 10, 2021
Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use
GILEAD SCIENCES INC25 citations93
US11897892B2Feb 13, 2024
Substituted pyridotriazine compounds and uses thereof
GILEAD SCIENCES INC6 citations85
US11753399B2Sep 12, 2023
Therapeutic compounds
GILEAD SCIENCES INC7 citations85
US12024528B2Jul 2, 2024
Bridged tricyclic carbamoylpyridone compounds and uses thereof
GILEAD SCIENCES INC6 citations84
US11613546B2Mar 28, 2023
Substituted pyridotriazine compounds and uses thereof
GILEAD SCIENCES INC9 citations84
US11548902B1Jan 10, 2023
Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use
GILEAD SCIENCES INC7 citations84
US8809266B2Aug 19, 2014
Antiviral compounds
GILEAD SCIENCES INC8 citations84
US12187734B2Jan 7, 2025
Substituted pyridotriazine compounds and uses thereof
GILEAD SCIENCES INC1 citations74
US11267801B2Mar 8, 2022
Therapeutic compounds
GILEAD SCIENCES INC4 citations73
US10442804B2Oct 15, 2019
Compounds for the treatment of hepatitis B virus infection
GILEAD SCIENCES INC4 citations73
US12054496B2Aug 6, 2024
Bridged tricyclic carbamoylpyridone compounds and uses thereof
GILEAD SCIENCES INC2 citations72
US12404262B2Sep 2, 2025
Therapeutic compounds for HIV virus infection
GILEAD SCIENCES INC1 citations63
US12227520B2Feb 18, 2025
Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use
GILEAD SCIENCES INC0 citations62
US12421235B2Sep 23, 2025
Bridged tricyclic carbamoylpyridone compounds and uses thereof
GILEAD SCIENCES INC0 citations60